Trends in Drug Resistance in Childhood Tuberculosis in Cape Town, South Africa. Issue 7 (July 2020)

• Record Type: Journal Article
• Authors: Schaaf, H. Simon; Garcia-Prats, Anthony J.; Draper, Heather R.; Rautenbach, Corné; Bosch, Corné; Demers, Anne-Marie; Hesseling, Anneke C.; Walters, Elisabetta
• Is Part Of: Pediatric infectious disease journal. Volume 39:Issue 7(2020)
• Publication Date: 2020-07
• Subjects: multidrug-resistant TB -- rifampicin-resistant/isoniazid-susceptible TB -- drug susceptibility testing -- Xpert MTB/RIF -- fluoroquinolone resistance; Communicable diseases in children -- Periodicals; Infection in children -- Periodicals; 618.929
• DOI: 10.1097/INF.0000000000002631
• Languages: English
• ISSNs: 0891-3668

Abstract

Abstract : Background: We determined mycobacterial drug resistance and HIV prevalence among children with bacteriologically confirmed tuberculosis (TB) from March 2013 to February 2017. Results were compared with 5 previous 2-year surveillance studies (2003–2013). Methods: Prospective surveillance of all bacteriologically confirmed TB in children (0–13 years) completed at Tygerberg Hospital, Cape Town, South Africa. Drug susceptibility testing was done by GenoType MTBDR plus for isoniazid and rifampicin; ofloxacin and amikacin drug susceptibility testing was completed if rifampicin resistance was detected. Xpert MTB/RIF was routinely introduced during this period. Results: Six hundred sixty-two children, median age 34 months (interquartile range 14–79) had bacteriologically confirmed TB; 587 (88.7%) were culture-confirmed and 75 (11.3%) confirmed by Xpert MTB/RIF only. Of culture-confirmed cases, 509 (86.7%) were pan-susceptible, 47 (8.0%) were multidrug-resistant, 13 (2.2%) were RIF-resistant/INH-susceptible and 18 (3.1%) were INH-resistant/RIF-susceptible. Of Xpert-positive cases, 3/75 (4%), 68/75 (92%) and 4/75 (5%) were RIF-resistant, RIF-susceptible and RIF-indeterminate, respectively. Of 573 (97.6%) children tested, 74 (12.9%) were HIV positive. Compared with previous surveillance periods, RIF mono-resistance increased from 0% to 2.2% (trend test: χ 2 = 7.050, P = 0.0079). HIV prevalence decreased from 29% to 10.6% (trend test: χ 2 = 27.975, P < 0.0001). Of multidrug-resistant cases, 15/47 (32%) were ofloxacin resistant. Conclusions: The increase in RIF-resistant/INH-susceptible cases and ofloxacin resistance among multidrug-resistant TB cases in children, indicative of recent transmission, is concerning. The prevalence of multidrug-resistant TB remains high in children. Abstract : Supplemental Digital Content is available in the text.